PDCD1 and neoplasm: Research involving murine models has demonstrated that tumor‐bearing mice exhibit a reduced response to PD‐1 antibody immunotherapy following the administration of broad‐spectrum antibiotics, underscoring the importance of a balanced gut microbiota for effective antitumor immune responses [150].